跳至主要内容
临床试验/NCT03214393
NCT03214393Unknown不适用

Role of Maternal Anticardiolipin and Anti-B2 Glycoprotein I Antibodies in Correlation With Fetal Doppler in Prediction of Adverse Pregnancy Outcome in Patients With Preeclampsia

Cairo University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
percentage of cases that develop severe pre-eclampsia

研究概览

简要总结

Relation of certain maternal serum antibodies to Doppler changes will be studied in cases suffering from hypertension with pregnancy.

详细描述

Assessment will be done for maternal serum anti-beta 2 glycoprotein 1 antibodies and anticardiolipin antibodies in cases of preeclampsia after 32 weeks of pregnancy. In addition, fetal Doppler changes will be assessed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women 32 weeks or more gestational age
  • Pre-eclampsia
  • Singleton pregnancy

排除标准

  • Intrauterine fetal death
  • Fetus with apparent congenital anomalies
  • Pregnant females with other medical disorders
  • History of essential hypertension.
  • History of antepartum hemorrhage.
  • History of rupture of membranes.

结局指标

主要结局

percentage of cases that develop severe pre-eclampsia

时间窗: It will be calculated after 1 year from the start of the study

percentage of cases that develop severe pre-eclampsia will be assessed by an investigator

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Doaa Shafie Belal

Principal investigator

Cairo University

研究点 (1)

Loading locations...

相似试验